Transpharmation Ltd.

Transpharmation Ltd, based in London, UK, is a small, active company established 14 years ago. With 25 employees and £7,711,207 in assets, it operates from a real address and is overseen by three directors and one owner. The company regularly imports optical and medical tools and devices (6 months of activity, latest in December 2024) and occasionally exports pharmaceutical products (2 months of activity, latest in January 2025). It’s a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50.

Transpharmation Ltd functions as a preclinical neuroscience contract research organisation (CRO), offering services to accelerate drug discovery programs. Its website highlights expertise in translational biology, offering a range of services including Alzheimer's disease research, bioanalytical studies, and safety studies. The company boasts access to the largest laboratory beagle colony worldwide, enabling unique research into age-related conditions. It even announced a strategic acquisition of Saretius Ltd in April 2025. The website also features a blog, news conferences, and a careers section, alongside contact details and social media links.

Financially, Transpharmation Ltd presents a mixed picture. Cash bank on hand increased significantly by 82%, reaching £4,300,000, while current assets grew by 61% to £7,700,000. However, net assets also increased by 74% to £6,600,000. Trade debtors increased by 40% to £3,400,000, and creditors rose by 9.3% to £1,200,000. The company’s property, plant, and equipment saw a decrease in value, with a 73% drop in total value. It's worth noting that the company’s average number of employees decreased slightly, from 25 to 24. With no auditor mentioned, the accounts are unaudited and prepared under FRS 102. The company’s financial trends suggest it's growing but also facing increased debt, potentially indicating a period of investment or expansion—although it could also be a sign of cash flow challenges.

Registered in England/Wales under the registration number 07348226, with a registered address at NW1 0NH, London, The London Bioscience Innovation Centre, 2 Royal College Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.